DeutschNewstral
Article
bizjournals.com on 2015-10-27 22:03
Seattle biotech inks deal worth up to $535M with Kite Pharma
Related news
- Former Triad biotech CEO lands with Seattle pharma companybizjournals.com
CFO Moves: Kite Pharmablogs.wsj.com- Seattle biotech paves the way for Alzheimer's drug trials, pharma licensing dealbizjournals.com
- FGilead in $11.9bn deal for Kite Pharmaft.com
Bridge Development inks Seattle dealdailyherald.com- MBiotech stocks surge on Gilead's Kite Pharma acquisitionmarketwatch.com
- Boulder biotech acquires Seattle companybizjournals.com
Israeli-founded Kite Pharma gets FDA nod for cancer therapytimesofisrael.com
Israeli-founded Kite Pharma Bought by Gilead for $11.9 BillionHaaretz
Washington, Seattle sue Purdue PharmaKING 5- Seattle biotech Adaptive lives up to its name, pivots toward drug developmentbizjournals.com
- Seattle biotech Faraday Pharmaceuticals names new CEObizjournals.com
Seattle biotech Adaptive buys San Francisco firmseattletimes.com- Seattle biotech expands portfolio with Boston acquisitionbizjournals.com
- Seattle biotech outpaces Washington's public companiesbizjournals.com
- Seattle biotech PhaseRx files to go publicseattletimes.com
- Seattle Genetics buys biotech factory in Bothellseattletimes.com
- Former Zillow CFO heads to Seattle biotechbizjournals.com
- Seattle biotech Silverback Therapeutics prices upsized IPOseattletimes.com